
Titan Medical TMDI
Annual report 2020
added 08-19-2023
Titan Medical Total Liabilities 2011-2026 | TMDI
Annual Total Liabilities Titan Medical
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 11.9 M | 43.6 M | 15.1 M | 17.7 M | 20.1 M | 6.6 M | 13.3 M | - | 1.19 M | 1.11 M | 1.97 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 43.6 M | 1.11 M | 13.3 M |
Quarterly Total Liabilities Titan Medical
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 8.86 M | 11.9 M | 24.6 M | 28.1 M | 29.6 M | 43.6 M | 24.5 M | 30.3 M | - | 15.1 M | 22.6 M | 39.5 M | - | 17.7 M | - | - | - | 20.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 43.6 M | 8.86 M | 24.3 M |
Total Liabilities of other stocks in the Medical devices industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aethlon Medical
AEMD
|
2.24 M | $ 2.2 | 4.27 % | $ 3.43 M | ||
|
AdaptHealth Corp.
AHCO
|
2.79 B | $ 10.72 | 2.88 % | $ 1.45 B | ||
|
Allied Healthcare Products
AHPI
|
3.56 M | - | 3.58 % | $ 2.21 M | ||
|
Butterfly Network
BFLY
|
87.2 M | $ 4.17 | 6.52 % | $ 883 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
129 M | - | - | $ 1.77 B | ||
|
Acutus Medical
AFIB
|
54.8 M | - | -26.83 % | $ 2.62 M | ||
|
Cognyte Software Ltd.
CGNT
|
281 M | $ 8.37 | -0.12 % | $ 601 M | ||
|
CONMED Corporation
CNMD
|
1.29 B | $ 36.49 | -2.47 % | $ 1.13 B | ||
|
Alphatec Holdings
ATEC
|
126 M | $ 12.76 | 1.23 % | $ 1.91 B | ||
|
Cytosorbents Corporation
CTSO
|
36.3 M | $ 0.69 | 6.49 % | $ 37.6 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
5.95 M | - | -5.86 % | $ 30.6 M | ||
|
Aziyo Biologics
AZYO
|
34.7 M | - | 1.37 % | $ 20.5 M | ||
|
Avinger
AVGR
|
20 M | - | -20.74 % | $ 369 K | ||
|
EDAP TMS S.A.
EDAP
|
45.2 M | $ 4.12 | 3.91 % | $ 154 M | ||
|
BIOLASE
BIOL
|
33.1 M | - | -13.19 % | $ 166 K | ||
|
Boston Scientific Corporation
BSX
|
16.7 B | $ 71.64 | 2.65 % | $ 106 B | ||
|
Establishment Labs Holdings
ESTA
|
334 M | $ 65.1 | 2.55 % | $ 1.93 B | ||
|
Conformis
CFMS
|
39.9 M | - | - | $ 16.4 M | ||
|
Apollo Endosurgery
APEN
|
77.6 M | - | - | $ 475 M | ||
|
Cutera
CUTR
|
518 M | - | -10.19 % | $ 1.99 M | ||
|
CryoLife, Inc.
CRY
|
461 M | - | -4.14 % | $ 702 M | ||
|
Dynatronics Corporation
DYNT
|
12.2 M | - | 14.99 % | $ 929 K | ||
|
ClearPoint Neuro
CLPT
|
13.8 M | $ 11.29 | 2.32 % | $ 305 M | ||
|
InMode Ltd.
INMD
|
83.2 M | $ 13.58 | 1.11 % | $ 878 M | ||
|
IRIDEX Corporation
IRIX
|
24.9 M | $ 1.31 | -1.5 % | $ 21.1 M | ||
|
Axonics Modulation Technologies
AXNX
|
89.2 M | - | - | $ 3.31 B | ||
|
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.44 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
21.1 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
57.2 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
14 M | - | - | $ 111 M | ||
|
FONAR Corporation
FONR
|
53.1 M | $ 18.44 | 0.11 % | $ 121 M | ||
|
Helius Medical Technologies
HSDT
|
5.34 M | $ 2.2 | 0.46 % | $ 1.34 M | ||
|
LivaNova PLC
LIVN
|
1.41 B | $ 62.23 | 1.29 % | $ 3.39 B | ||
|
GBS
GBS
|
5.44 M | - | -0.57 % | $ 7.12 M | ||
|
MiMedx Group
MDXG
|
86.1 M | $ 4.47 | 1.25 % | $ 661 M | ||
|
Intersect ENT, Inc.
XENT
|
160 M | - | - | $ 955 M | ||
|
Abbott Laboratories
ABT
|
36.6 B | $ 111.62 | 1.52 % | $ 194 B | ||
|
Delcath Systems
DCTH
|
12.4 M | $ 9.76 | -0.48 % | $ 350 M | ||
|
Bio-Rad Laboratories
BIO
|
2.79 B | $ 268.07 | 2.61 % | $ 7.56 B | ||
|
Nano-X Imaging Ltd.
NNOX
|
20.9 M | $ 2.59 | -0.19 % | $ 152 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
2.49 B | $ 9.19 | 2.0 % | $ 708 M | ||
|
AxoGen
AXGN
|
92.8 M | $ 32.83 | -0.05 % | $ 1.51 B | ||
|
Align Technology
ALGN
|
2.36 B | $ 176.11 | 3.93 % | $ 13.2 B | ||
|
Bruker Corporation
BRKR
|
3.99 B | $ 33.64 | 2.67 % | $ 5.01 K | ||
|
BioSig Technologies
BSGM
|
2.26 M | - | 37.08 % | $ 85.7 M | ||
|
Apyx Medical Corporation
APYX
|
52 M | $ 3.82 | 4.08 % | $ 157 M | ||
|
OrthoPediatrics Corp.
KIDS
|
162 M | $ 17.1 | -0.06 % | $ 401 M |